Pharmaceuticals Compounding Pharmacies Market Forec...

Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Oral Medications, Topical Medications, Suppositories, Others); Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, Others) and Geography

Publication Month: Mar 2021 | Report Code: TIPRE00005407 | No. of Pages: 149 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.

 

The major factors driving to the growth of the market are the drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (personalized medicine). However, product recalls and stringent regulatory requirements are restricting the Compounding Pharmacies market growth. Compounding pharmacy’s or compound pharmacy’s role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Compounding pharmacies are essential in cases of limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy, and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality.

 

In December 2020, Triangle Compounding Pharmacy launched compounded hand sanitizer to fight against COVID-19 pandemic. Triangle Compounding Pharmacy is the first to provide pharmaceutical-grade hand sanitizer in the US.  


Lucrative Regions for Compounding Pharmacies Market

Lucrative Regions for Compounding Pharmacies Market

Get more information on this report :


 

Market Insights


Drug Shortage Crisis Across the World

The US is encountering a rapid drug shortage, which has caused difficulties for health care facilities, clinicians, patients, and federal regulators. Challenges in manufacturing, acquisition of raw materials, regulatory issues, and business arrangements, as well as disruptions in the supply chain are the major factors causing drug shortage. According to the American Society of Health-System Pharmacists, drug shortages can negatively affect drug therapy and cause delay in medical procedures resulting in medication errors. Drug shortages range from simple medicines, such as buffered aspirin, to life-saving medications—such as cancer antibiotics and cancer chemotherapy agents—and emergency medications, such as epinephrine. Healthcare professionals, especially pharmacists, along with the US government and drug manufacturers, are consistently working on managing this public-health crisis. Health care personnel have started formulating solutions to overcome drug shortage. Compounding pharmacies are considered a viable source of drugs that are in short supply. Additionally, due to COVID-19 pandemic, the US Food and Drug Administration (USFDA) has identified 20 drugs with shortage risks.

 

Compounding pharmacies offer a great alternative to conventional medication dispensing that can be beneficial in times of crisis


Product-Based Insights

Based on product, the compounding pharmacies market is segmented into oral medications, topical medications, suppositories, and others. The oral medications segment held the largest share of the market in 2020. The growth of this segment can be attributed to the factors such as easy to consume and they come in different forms such as solid tablets, capsules, chewable tablets, and lozenges, which can be swallowed whole or sucked or as drinkable liquids such as syrups, drops, and solutions. Further, the compounding pharmacies market for topical medications segment is expected to grow at the fastest CAGR during 2021–2028.

 

Compounding Pharmacies Market, by Product – 2020 and 2028

Compounding Pharmacies Market, by Product – 2020 and 2028

Get more information on this report :


 

Therapeutic Area-Based Insights

Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The pain medications segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.

                                                                                                                                                               

Strategic Insights

Companies operating in the compounding pharmacies market adopt the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

 

Compounding Pharmacies Market – by Product

  • Oral Medications
  • Topical Medications
  • Suppositories
  • Others

Compounding Pharmacies Market – by Therapeutic Area

  • Pain Medications
  • Hormone Replacement Therapies (HRT)
  • Dermatological Applications
  • Others

Compounding Pharmacies Market– by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • Fagron, Inc.       
  • Elixir Compounding Pharmacy   
  • Avella specialty pharmacy        
  • B. Braun Melsungen AG
  • PharMEDium Healthcare Holdings, Inc.
  • Fresenius Kabi AG         
  • Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd
  • Triangle Compounding Pharmacy        
  • Vertisis Custom Pharmacy       
  • US Compounding Inc

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Compounding Pharmacies Market – By Product

1.3.2        Global Compounding Pharmacies Market – By Therapeutic Area

1.3.3        Global Compounding Pharmacies Market– By Geography

2.             Compounding Pharmacies Market– Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Compounding Pharmacies Market– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South and Central America PEST Analysis

4.3       Expert Opinion

5.             Compounding Pharmacies Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Drug Shortage Crisis Across the World

5.1.2        Benefits of Compounded Medications

5.1.3        Increasing Adoption of Customized Medicine (Personalized Medicine)

5.2       Market Restraints

5.2.1        Product Recalls and Stringent Regulatory Requirements

5.3       Market Opportunities

5.3.1        Growing Demand for Compounding Pharmacy During COVID-19

5.4       Future Trends

5.4.1        Growing Outsourcing Facilities for Manufacturing and Sales of Products

5.5       Impact Analysis

6.             Compounding Pharmacies Market– Global Analysis

6.1       Global Compounding Pharmacies Market Revenue Forecast and Analysis

6.2       Global Compounding Pharmacies Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.             Compounding Pharmacies Market Analysis – By Product

7.1       Overview

7.2       Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

7.3       Oral Medications

7.3.1        Overview

7.3.2        Oral Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.4       Topical Medications

7.4.1        Overview

7.4.2        Topical Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.5       Suppositories

7.5.1        Overview

7.5.2        Suppositories: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.6       Others

7.6.1        Overview

7.6.2        Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.             Compounding Pharmacies Market – By Therapeutic Area

8.1       Overview

8.2       Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

8.3       Pain Medications

8.3.1        Overview

8.3.2        Pain Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.4       Hormone Replacement Therapies

8.4.1        Overview

8.4.2        Hormone Replacement Therapies: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.5       Dermatological Applications

8.5.1        Overview

8.5.2        Dermatological Applications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.6       Others

8.6.1        Overview

8.6.2        Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.             Compounding Pharmacies Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1       North America Compounding Pharmacies Market Revenue and Forecasts to 2028

9.1.1        North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.1.1      North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.1.2      North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.2        North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.1.3        US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.4        US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.4.1      US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.4.2      US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.5        Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.5.1      Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.5.2      Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.5.3      Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.6        Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.6.1      Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.6.2      Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.6.3      Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2       Europe Compounding Pharmacies Market Revenue and Forecasts to 2028

9.2.1        Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.1.1      Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.1.2      Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.2        Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.2.3        UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.3.1      UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.3.2      UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.3.3      UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.4        Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.4.1.1       Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.4.2      Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.4.3      Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.4.4      France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.5        France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.5.1      France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.5.2      France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.6        Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.6.1      Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.6.2      Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.6.3      Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.7        Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.8        Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.8.1      Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.8.2      Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.9        Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.10     Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.10.1    Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.10.2    Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.3       Asia Pacific: Compounding Pharmacies Market

9.3.1        Overview

9.3.2        Asia Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)

9.3.3        Asia Pacific: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.4        Asia Pacific: Compounding Pharmacies Market, by Therapeutic Area – 2019–2028 (USD Million)

9.3.5        Asia Pacific: Compounding Pharmacies Market, by Country, 2020 & 2028 (%)

9.3.6        China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.6.1      China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.6.2      China: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.6.3      China: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.7        Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.7.1      Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.7.2      Japan: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.7.3      Japan: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.8        India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.8.1      India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.8.2      India: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.8.3      India: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.9        South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.9.1      South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.9.2      South Korea: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.9.3      South Korea: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.10     Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.10.1    Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.10.2    Australia: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.10.3    Australia: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.11     Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.11.1    Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.11.2    Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

9.3.11.3    Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

9.4       East & Africa: Compounding Pharmacies Market

9.4.1        Overview

9.4.2        Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028  (USD Million)

9.4.3        Middle East and Africa: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.4        Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.5        Middle East and Africa: Compounding Pharmacies Market, by Country, 2020& 2028 (%)

9.4.6        UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.6.1      UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.6.2      UAE: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.6.3      UAE: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.7        Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1      Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.7.2      Saudi Arabia: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.7.3      Saudi Arabia: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.8        South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.8.1      South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.8.2      South Africa: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.8.3      South Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.9        Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.4.9.1      Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.9.2      Rest of Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

9.4.9.2.1       Rest of Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.5       South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028

9.5.1        South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.1.1      South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.1.2      South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.5.2        South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.5.3        Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.4        Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.4.1      Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.4.2      Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.5.5        Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.6        Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.6.1      Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.6.2      Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.5.7        Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028  (US$ Mn)

9.5.8        Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028  (US$ Mn)

9.5.8.1      Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.8.2      Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

10.          Impact Of COVID-19 Pandemic on Global Compounding Pharmacies Market

10.1    North America: Impact Assessment of COVID-19 Pandemic

10.2    Europe: Impact Assessment of COVID-19 Pandemic

10.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4    Rest of The World: Impact Assessment of COVID-19 Pandemic

11.          Compounding Pharmacies Market– Industry Landscape

11.1    Overview

11.2    Growth Strategies Done by the Companies in the Market, (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic Developments

11.4.1     Overview

12.          Company Profiles

12.1    Fagron, Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Triangle Compounding Pharmacy

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    B.Braun Melsungen AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    PharMEDium Healthcare Holdings, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Fresenius Kabi AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Avella specialty pharmacy

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Vertisis Custom Pharmacy

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    US Compounding Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Elixir Compounding Pharmacy

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.          Appendix

13.1    About the Insight Partners

13.2    Glossary of Terms

LIST OF TABLES

Table 1.             A few drugs that are in short supply are listed below:

Table 2.             North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.             North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 4.             US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 5.             US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 6.             Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 7.             Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 8.             Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 9.             Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 10.          Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 11.          Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 12.          UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 13.          UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 14.          Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 15.          Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 16.          France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17.          France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 18.          Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 19.          Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 20.          Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 21.          Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 22.          Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 23.          Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area  (US$ Mn)

Table 24.          Asia Pacific Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 25.          Asia Pacific Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028  (USD Million)

Table 26.          China Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 27.          China Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 28.          Japan Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 29.          Japan Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 30.          India Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 31.          India Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 32.          South Korea Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 33.          South Korea Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028  (USD Million)

Table 34.          Australia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 35.          Australia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 38.          Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 39.          Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 40.          UAE Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 41.          UAE Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 42.          Saudi Arabia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 43.          Saudi Arabia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 44.          South Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 45.          South Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028  (USD Million)

Table 46.          Rest of Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 47.          Rest of Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 48.          South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 49.          South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 50.          Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 51.          Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 52.          Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 53.          Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 54.          Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 55.          Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 56.          Organic Developments Done By Companies

Table 57.          Inorganic Developments Done By Companies

Table 58.          Glossary of Terms, Compounding Pharmacies Market

 

LIST OF FIGURES

Figure 1.           Compounding Pharmacies Market Segmentation

Figure 2.           Compounding Pharmacies Segmentation, By Region

Figure 3.           Global Compounding Pharmacies Market Overview

Figure 4.           Oral Medications Held Largest Share of Product Segment in Compounding Pharmacies Market

Figure 5.           North America to Show Remarkable Growth During Forecast Period

Figure 6.           Compounding Pharmacies Market, by Geography (US$ Million)

Figure 7.           Global Compounding Pharmacies Market– Leading Country Markets (US$ Million)

Figure 8.           Global Compounding Pharmacies Market, Industry Landscape

Figure 9.           North America: PEST Analysis

Figure 10.        Europe: PEST Analysis

Figure 11.        Asia Pacific: PEST Analysis

Figure 12.        Middle East & Africa: PEST Analysis

Figure 13.        South and Central America: PEST Analysis

Figure 14.        Compounding Pharmacies Market Impact Analysis of Drivers and Restraints

Figure 15.        Global Compounding Pharmacies Market– Revenue Forecast and Analysis – 2020- 2028

Figure 16.        Global Compounding Pharmacies Market– By Geography Forecast and Analysis – 2020- 2028

Figure 17.        Market Positioning of Key Players in Global Compounding Pharmacies Market

Figure 18.        Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

Figure 19.        Oral Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Topical Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Suppositories: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

Figure 24.        Pain Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Hormone Replacement Therapies: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Dermatological Applications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 29.        North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 31.        US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        Canada Compounding Pharmacies Market Revenue And Forecasts to 2028 (US$ Mn)

Figure 33.        Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        Europe Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 35.        Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36.        Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 37.        UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38.        Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 39.        France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 43.        Asia Pacific: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)

Figure 44.        Asia Pacific Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Million)

Figure 45.        China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.        Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.        South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Middle East & Africa: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)

Figure 52.        Middle East and Africa Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Millions)

Figure 53.        UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 54.        Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 55.        South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 56.        Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028  (USD Million)

Figure 57.        South and Central America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 58.        South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 59.        South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 60.        Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 61.        Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 62.        Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 63.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 64.        Impact of COVID-19 Pandemic in European Country Markets

Figure 65.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 66.        Impact Of COVID-19 Pandemic in Rest of The World Market

Figure 67.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Compounding Pharmacies Market

  1. Fagron, Inc.           
  2. Elixir Compounding Pharmacy        
  3. Avella specialty pharmacy  
  4. B. Braun Melsungen AG      
  5. PharMEDium Healthcare Holdings, Inc.        
  6. Fresenius Kabi AG
  7. Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd         
  8. Triangle Compounding Pharmacy    
  9. Vertisis Custom Pharmacy  
  10. US Compounding Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the compounding pharmacies market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global compounding pharmacies market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00005407
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality. Additionally, as per law, compounding drugs does not include making copies of commercially available drug products. Compounding pharmacists can make flavored drugs in different dosage forms, such as liquids, topical creams, suppositories, transdermal gels, or other dosage forms suitable for patient's unique needs.

The factors that are driving growth of the market are drug shortage crisis across the globe, benefits associated with compounded medications and increasing adoption of customized medicine (Personalized medicine).

The compounding pharmacies market majorly consists of the players such as Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc.

Pricing
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved